# DEFERASIROX
> **ANDA213374** · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2020-07-14
## Drug
- **FDA Application Number:** ANDA213374
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFERASIROX
- **Generic name:** DEFERASIROX ORAL
- **Active ingredients:** DEFERASIROX
- **Dosage form:** GRANULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALKEM LABS LTD
- **Manufacturer:** Ascend Laboratories, LLC
- **First approval:** 2020-07-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213374)
---
*AI Analytics · CC0 1.0*